Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells

Copyright © 2023 by The American Association of Immunologists, Inc..

IL-2 has been proposed to restore tolerance via regulatory T cell (Treg) expansion in autoimmunity, yet off-target effects necessitate identification of a combinatorial approach allowing for lower IL-2 dosing. We recently reported reduced levels of immunoregulatory insulin-like growth factor-1 (IGF1) during type 1 diabetes progression. Thus, we hypothesized that IGF1 would synergize with IL-2 to expand Tregs. We observed IGF1 receptor was elevated on murine memory and human naive Treg subsets. IL-2 and IGF1 promoted PI3K/Akt signaling in Tregs, inducing thymically-derived Treg expansion beyond either agent alone in NOD mice. Increased populations of murine Tregs of naive or memory, as well as CD5lo polyclonal or CD5hi likely self-reactive, status were also observed. Expansion was attributed to increased IL-2Rγ subunit expression on murine Tregs exposed to IL-2 and IGF1 as compared with IL-2 or IGF1 alone. Assessing translational capacity, incubation of naive human CD4+ T cells with IL-2 and IGF1 enhanced thymically-derived Treg proliferation in vitro, without the need for TCR ligation. We then demonstrated that IGF1 and IL-2 or IL-7, which is also IL-2Rγ-chain dependent, can be used to induce proliferation of genetically engineered naive human Tregs or T conventional cells, respectively. These data support the potential use of IGF1 in combination with common γ-chain cytokines to drive homeostatic T cell expansion, both in vitro and in vivo, for cellular therapeutics and ex vivo gene editing.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:211

Enthalten in:

Journal of immunology (Baltimore, Md. : 1950) - 211(2023), 7 vom: 01. Okt., Seite 1108-1122

Sprache:

Englisch

Beteiligte Personen:

Shapiro, Melanie R [VerfasserIn]
Peters, Leeana D [VerfasserIn]
Brown, Matthew E [VerfasserIn]
Cabello-Kindelan, Cecilia [VerfasserIn]
Posgai, Amanda L [VerfasserIn]
Bayer, Allison L [VerfasserIn]
Brusko, Todd M [VerfasserIn]

Links:

Volltext

Themen:

67763-96-6
EC 2.7.1.-
Insulin-Like Growth Factor I
Interleukin-2
Journal Article
Phosphatidylinositol 3-Kinases
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 20.09.2023

Date Revised 28.09.2023

published: Print

Citation Status MEDLINE

doi:

10.4049/jimmunol.2200651

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM360931251